Showing results (701-710 of 1,995) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|September 11, 2007
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiativeRosa Rademakers, Matt Baker, Jennifer Gass, et al.The Lancet. Neurology|May 19, 2007
Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based studyC E Lovelock, A J Molyneux, P M Rothwell, et al.The Lancet. Neurology|May 19, 2007
Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational studyPhilip Shaw, Jason P Lerch, Jens C Pruessner, et al.The Lancet. Neurology|May 19, 2007
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trialWerner H Poewe, Olivier Rascol, Niall Quinn, et al.The Lancet. Neurology|May 19, 2007
Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic reviewTu Luong Mac, Duc-Si Tran, Fabrice Quet, et al.The Lancet. Neurology|November 28, 2016
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trialMichel Baulac, Felix Rosenow, Manuel Toledo, et al.The Lancet. Neurology|March 3, 2015
Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexyRoland S Liblau, Anne Vassalli, Ali Seifinejad, et al.The Lancet. Neurology|March 26, 2021
Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort studyKathrin Reetz, Imis Dogan, Ralf-Dieter Hilgers, et al.The Lancet. Neurology|April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional studyAndrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.The Lancet. Neurology|March 14, 2015
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trialRonit M Pressler, Geraldine B Boylan, Neil Marlow, et al.Pageof 200